Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR24029-128] to ALK - BSA and Azide free
  • Suitable for: IP, WB
  • Reacts with: Mouse, Rat, Human

Overview

  • Product name

    Anti-ALK antibody [EPR24029-128] - BSA and Azide free
    See all ALK primary antibodies

  • Description

    Rabbit monoclonal [EPR24029-128] to ALK - BSA and Azide free

  • Host species

    Rabbit

  • Tested applications

    Suitable for: IP, WBmore details
    Unsuitable for: Flow Cyt,ICC/IF,IHC-Fr or IHC-P

  • Species reactivity

    Reacts with: Mouse, Rat, Human

  • Immunogen

    Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: Mouse P5 brain tissue lysate; Rat P0 brain tissue lysate; Neuro-2a,SK-N-BE(2), IMR032 and SH-SY5Y whole cell lysates. IP: Neuro-2a and IMR-32 whole cell lysates.

  • General notes

    ab275968 is the carrier-free version of ab275964.

    Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.

    This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

    Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with

    This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Western blot - Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)
    Western blot - Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)
    All lanes : Anti-ALK antibody [EPR24029-128] (ab275964) at 1/1000 dilution

    Lane 1 : Mouse P5 brain tissue lysate
    Lane 2 : Mouse kidney tissue lysate
    Lane 3 : Neuro-2a (mouse neuroblastoma neuroblast) whole cell lysate
    Lane 4 : Rat P0 brain tissue lysate
    Lane 5 : Rat kidney tissue lysate

    Lysates/proteins at 40 µg per lane.

    Secondary
    All lanes : VeriBlot for IP secondary antibody(HRP)(ab131366) at 1/1000 dilution

    Predicted band size: 176 kDa
    Observed band size: 140-250 kDa
    why is the actual band size different from the predicted?



    This data was developed using ab275964, the same antibody clone in a different buffer formulation. 

    Blocking and diluting buffer and concentration: 5% NFDM/TBST.

    ALK undergoes glycosylation and phosphorylation. ALK has both extracellular and intracellular cleavage sites. The molecular weight observed are consistent with what have been described in literatures (PMID: 30541790, 32344689).

    Negative control: kidney (PMID: 9053841).

    This blot was developed using a higher sensitivity ECL substrate.

    Exposure time: 3 minutes.

  • Immunoprecipitation - Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)
    Immunoprecipitation - Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)

    This data was developed using ab275964, the same antibody clone in a different buffer formulation.

    ALK was immunoprecipitated from 0.35 mg Neuro-2a (mouse neuroblastoma neuroblast) whole cell lysate with ab275964 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab275964 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/1000 dilution.

    Lane 1: Neuro-2a (mouse neuroblastoma neuroblast) whole cell lysate 10 ug

    Lane 2: ab275964 IP in Neuro-2a whole cell lysate

    Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab275964 in Neuro-2a whole cell lysate

    Blocking and dilution buffer and concentration: 5% NFDM/TBST.

    Exposure time: 3 minutes.

     

  • Western blot - Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)
    Western blot - Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)
    All lanes : Anti-ALK antibody [EPR24029-128] (ab275964) at 1/1000 dilution

    Lane 1 : SK-N-BE(2) (human neuroblastoma neuroblast) whole cell lysate
    Lane 2 : IMR-32 (human neuroblastoma neuroblast) whole cell lysate
    Lane 3 : SH-SY5Y (human neuroblastoma epithelial cell) whole cell lysate
    Lane 4 : Raji (human burkitts lymphoma b lymphocyte) whole cell lysate
    Lane 5 : Ramos (human burkitts lymphoma b lymphocyte) whole cell lysate

    Lysates/proteins at 40 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/50000 dilution

    Predicted band size: 176 kDa
    Observed band size: 140-250,70 kDa why is the actual band size different from the predicted?



    This data was developed using ab275964, the same antibody clone in a different buffer formulation. 

    Blocking and diluting buffer and concentration: 5% NFDM/TBST.

    ALK undergoes glycosylation and phosphorylation. ALK has both extracellular and intracellular cleavage sites. The 140-250 kDa bands observed are consistent with what have been described in literatures (PMID: 30541790, 32344689).

    A 70-kDa band is observed, it may correspond to N terminal truncated ALK (PMID: 30400214).

    Negative control: Raji and Ramos (PMID: 30541790).

    Exposure time: 26 seconds.

  • Immunoprecipitation - Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)
    Immunoprecipitation - Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)

    This data was developed using ab275964, the same antibody clone in a different buffer formulation.

    ALK was immunoprecipitated from 0.35 mg IMR-32 (human neuroblastoma neuroblast) whole cell lysate with ab275964 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab275964 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.

    Lane 1: IMR-32 (human neuroblastoma neuroblast) whole cell lysate 10 ug

    Lane 2: ab275964 IP in IMR-32 whole cell lysate

    Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab275964 in IMR-32 whole cell lysate

    Blocking and dilution buffer and concentration: 5% NFDM/TBST.

    Exposure time: 119 seconds.

     

  • Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)
    Anti-ALK antibody [EPR24029-128] - BSA and Azide free (ab275968)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

© 2021 Astana Biomed Group LLP. All rights reserved.